ICU Medical Inc: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 7, 2014 and accepted by EDGAR at May 7, 2014, 16:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-01-01 to 2014-03-31 | $73.2m | us-gaap:Revenues |
| Cost of revenue | 3 months2014-01-01 to 2014-03-31 | $37.2m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-01-01 to 2014-03-31 | $36.0m | us-gaap:GrossProfit |
| Research and development | 3 months2014-01-01 to 2014-03-31 | $3.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-01-01 to 2014-03-31 | $22.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-01-01 to 2014-03-31 | $9.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-01-01 to 2014-03-31 | $3.4m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | $0.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-01-01 to 2014-03-31 | $0.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-01-01 to 2014-03-31 | 15,395,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2014-01-01 to 2014-03-31 | $12.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2014-01-01 to 2014-03-31 | $5.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2014-01-01 to 2014-03-31 | $5.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-03-31 | $227.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-03-31 | $400.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-31 | $506.4m | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $25.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-03-31 | $474.2m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0000883984-14-000036. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.